Seres Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MCRB and other ETFs, options, and stocks.About MCRB
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401.
CEOThomas J. DesRosier
CEOThomas J. DesRosier
Employees103
Employees103
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2010
Founded2010
Employees103
Employees103
MCRB Key Statistics
Market cap150.23M
Market cap150.23M
Price-Earnings ratio27.44
Price-Earnings ratio27.44
Dividend yield—
Dividend yield—
Average volume152.52K
Average volume152.52K
High today$17.82
High today$17.82
Low today$16.53
Low today$16.53
Open price$17.78
Open price$17.78
Volume90.15K
Volume90.15K
52 Week high$29.98
52 Week high$29.98
52 Week low$6.53
52 Week low$6.53
Stock Snapshot
As of today, Seres Therapeutics(MCRB) shares are valued at $17.50. The company's market cap stands at 150.23M, with a P/E ratio of 27.44.
As of 2025-12-06, Seres Therapeutics(MCRB) stock has fluctuated between $16.53 and $17.82. The current price stands at $17.50, placing the stock +5.9% above today's low and -1.8% off the high.
Seres Therapeutics(MCRB) shares are trading with a volume of 90.15K, against a daily average of 152.52K.
During the past year, Seres Therapeutics(MCRB) stock moved between $6.53 at its lowest and $29.98 at its peak.
During the past year, Seres Therapeutics(MCRB) stock moved between $6.53 at its lowest and $29.98 at its peak.
People also own
Based on the portfolios of people who own MCRB. This list is generated using Robinhood data, and it’s not a recommendation.